Nemesis
Seongnam
About Nemesis
Nemesis provides bio and medical device vendors and service providers with Intelligent biosignal processing solutions. Nemesis has technologies like biosensors, bio-signal processing, and wireless communication, which provide compact, low-power, and accurate semiconductor solutions that anyone can use. Nemesis semiconductor-based intelligent bio signal processing solution can be expanded to diagnose biomarkers in areas such as heart rate, electrocardiogram, blood pressure, and virus detection. Nemesis will do everything possible to improve the quality of our partners' products and services as a result of this.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.1M
- Funding stage: Seed
- Last round: Seed (Jun 2021)
- Website: nemesis.kr
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical Device, Semiconductor
Social Profiles
Canonical: https://fsome.com/organization/nemesis-21839 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.